| Q128778907 | A Review of Multiple Sclerosis for Urologists and Urogynecologists with an Emphasis on Management |
| Q27021610 | A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men With Benign Prostatic Hyperplasia |
| Q129655064 | AUA Guidelines on Stress Urinary Incontinence: What Is New in the Guidelines? |
| Q104461129 | Advances in pharmacotherapy for the treatment of overactive bladder |
| Q34176834 | Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors |
| Q128997980 | Challenges of Training General Surgery Residents to Do Urology in the Developing World |
| Q126813889 | Classification, Characterization, and Sub-Grouping of Interstitial Cystitis |
| Q39128009 | Conditional Electrical Stimulation in Animal and Human Models for Neurogenic Bladder: Working Toward a Neuroprosthesis |
| Q126639233 | Consequences of Pelvic Radiotherapy on Urinary Function in Women |
| Q60724730 | Conservative strategies for the treatment of stress urinary incontinence |
| Q108257615 | Contemporary Evaluation and Treatment of Male Urethral Stricture Disease in West Africa |
| Q129391385 | Contemporary Treatment of Detrusor Sphincter Dyssynergia: a Systematic Review |
| Q129634982 | Cost-Effectiveness of Third-Line Therapies for Overactive Bladder |
| Q128536476 | Cost-effectiveness of Medical Versus Surgical Therapy for BPH |
| Q126055117 | Creating an Inclusive Urology Practice |
| Q62626326 | Current State of the Art in Non-Invasive Urodynamics |
| Q128997934 | Current Update on Management of Male Stress Urinary Incontinence |
| Q126653214 | Detrusor Underactivity and Underactive Bladder in Women: What Is New? |
| Q104461126 | Dilemmas in Management of the Geriatric Bladder |
| Q129408962 | Does Urodynamics Impact the Outcomes of Third-line Therapy of Refractory OAB (or Refractory Urgency Urinary Incontinence)? |
| Q60724665 | Dorsal Genital Nerve Stimulation for Neurogenic Bladder |
| Q60724692 | Effects of stress on male voiding function |
| Q57352723 | Endoscopic Treatment of Vesicoureteral Reflux |
| Q94503180 | Evaluation and Management of Lower Urinary Tract Symptoms After Outlet Surgery for Benign Prostatic Hyperplasia |
| Q34703364 | Expanding the Role of Neuromodulation for Overactive Bladder: New Indications and Alternatives to Delivery |
| Q34703380 | Female Urethral Reconstruction |
| Q36310610 | Functional Outcomes for Incontinence and Prolapse Surgery |
| Q91083414 | Functional brain imaging in voiding dysfunction |
| Q38680911 | Future Perspectives in Bladder Tissue Engineering |
| Q127497662 | Historical and Current Concepts Regarding Urodynamics in Multiple Sclerosis Patients |
| Q35173812 | History and Future of Multi-Institutional Clinical Trials in Urinary Incontinence |
| Q129688929 | How to Diagnose Dysfunctional Voiding |
| Q113186605 | Improving Health Literacy Among Underserved Latinas with PFDs |
| Q129817500 | Insight Into the Central Control of Overactive Bladder Symptoms by Functional Brain Imaging |
| Q127521826 | Intraoperative Tips and Tricks for Successful Sacral Neuromodulation |
| Q128985695 | Is There Still a Role for Transvaginal Mesh in Treatment of Pelvic Organ Prolapse? |
| Q126822561 | Is Vaginal Laser Effective for Overactive Bladder? Results of a Systematic Review |
| Q92540434 | Is the Diabetic Bladder a Neurogenic Bladder? Evidence from the Literature |
| Q129723515 | Ketamine-Associated Bladder Dysfunction—a Review of the Literature |
| Q63352990 | Long-Term Sequela of Pediatric Bladder Reconstruction |
| Q130005176 | Machine Learning and Artificial Intelligence to Improve Interpretation of Urodynamics |
| Q127496033 | Management of Overactive Bladder After Treatment of Bladder Outlet Obstruction |
| Q129703048 | Managing of Lower Urinary Tract Dysfunction Following Stroke |
| Q127965828 | Mathematical Modeling and Uroflow-Based Nomograms in Voiding Dysfunction Evaluation: Ready for Prime Time? |
| Q36586375 | Mixed Incontinence: How Best to Manage It? |
| Q127929853 | Molecular Characteristics of Underactive Bladder |
| Q91831535 | NEW CONCEPTS IN BLADDER SENSATION AND URINARY URGENCY |
| Q129383575 | Neurogenic Bladder: Recurrent Urinary Tract Infections—Beyond Antibiotics |
| Q38656183 | Neurogenic Bowel Dysfunction in Patients with Neurogenic Bladder |
| Q36405172 | Neurogenic Causes of Detrusor Underactivity |
| Q64937302 | Neuromodulation for Neurogenic Bladder. |
| Q92644730 | New Diagnostics for Male Lower Urinary Tract Symptoms |
| Q47334117 | New frontiers in molecular and imaging research on evaluation and diagnosis of bladder outlet obstruction in women |
| Q120562140 | Non-invasive Testing and Its Role in Diagnosis and Management of Children With Voiding Dysfunction |
| Q36630704 | Objective Evaluation of Overactive Bladder: Which Surveys Should I Use? |
| Q129150594 | Optimizing Postoperative Pain Management in Pelvic Floor Surgery |
| Q127521493 | Outcomes of Bladder Preservation Following Treatment for Rhabdomyosarcoma |
| Q37025381 | PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH. |
| Q39455816 | Pathophysiology of the Underactive Bladder: Evolving New Concepts |
| Q42806518 | Pelvic Organ Prolapse-Associated Cystitis |
| Q92922391 | Physical Activity and Stress Incontinence in Women |
| Q129720909 | Post-Implant Management of Sacral Neuromodulation |
| Q126627559 | Post-Prostatectomy Incontinence: an Update on Current Management |
| Q129335915 | Prevalence and Cost of Catheters to Manage Neurogenic Bladder |
| Q128521844 | Recent Non-neurogenic Overactive Bladder Trials |
| Q127463123 | Rectourethral Fistula: Operative Technique and Outcomes |
| Q114871769 | Recurrent Urinary Tract Infections and Asymptomatic Bacteriuria in Adults |
| Q57395933 | Regenerative medicine and the neurogenic bladder |
| Q35180312 | Robotics for Pelvic Reconstruction |
| Q34973917 | Role of Purinergic Signaling in Voiding Dysfunction |
| Q63352991 | Sacral Neuromodulation in Children |
| Q129403946 | Safely Avoiding Surgery in Adult Neurogenic Bladder |
| Q129244401 | Shared Pathophysiology of Detrusor Overactivity and Detrusor Underactivity |
| Q127873908 | Sling Procedures for Post Prostatectomy Incontinence: What Devices Are Out There? and What Are Their Results? |
| Q129490665 | Stress Urinary Incontinence Management in the Patient With Overactive Bladder |
| Q129733765 | Stress Urinary Incontinence in Women with Neurogenic Lower Urinary Tract Dysfunction |
| Q46817158 | The Aging Overactive Bladder: A Review of Aging-Related Changes from the Brain to the Bladder |
| Q127592265 | The Argument For and Against the Use of Multichannel Urodynamics in the Assessment of Post-Prostatectomy Incontinence |
| Q96953943 | The Bladder is Not Sterile: an Update on the Urinary Microbiome |
| Q36767014 | The Burden of Overactive Bladder on US Public Health |
| Q127902997 | The Current Role of Botox in a Pediatric Neurogenic Bladder Condition |
| Q128035986 | The Effect of Major Pelvic Extirpative Surgery on Lower Urinary Tract Function |
| Q28076967 | The Management of the Pediatric Neurogenic Bladder |
| Q126200055 | The Robotic Appendicovesicostomy and Bladder Augmentation |
| Q130085032 | The Role of Bowel Management in Children with Bladder and Bowel Dysfunction |
| Q127578078 | The Role of Estrogen Status in the Causation of Female Lower Urinary Tract and Pelvic Floor Dysfunction |
| Q57582241 | The Role of Inflammation in the Progression of Benign Prostatic Hyperplasia |
| Q36450134 | The Worldwide Economic Impact of Neurogenic Bladder |
| Q36895628 | The bladder is not sterile: History and current discoveries on the urinary microbiome. |
| Q129076893 | Tibial Nerve and Sacral Neuromodulation in the Multiple Sclerosis Patient with Voiding Dysfunction |
| Q126587774 | Treatment of Refractory Urinary Urgency, Frequency, and Incontinence in Pregnancy |
| Q129817509 | Trends in Utilization of Third-Line Therapies for Non-neurogenic Overactive Bladder: Sacral Neuromodulation, Peripheral Tibial Nerve Stimulation, and Intradetrusor OnabotulinumtoxinA |
| Q42538258 | Two-micron (Thulium) Laser Prostatectomy: An Effective Method for BPH Treatment |
| Q95936940 | Underactive Bladder and Bladder Outlet Procedures in Women |
| Q129308938 | Unresolved Pyuria |
| Q63352988 | Urinary Biomarkers Under Investigation for Overactive Bladder Syndrome |
| Q128525876 | Use and Outcomes of Botulinum Toxin A for Both Neurogenic and Non-neurogenic Voiding Dysfunction in the Pediatric Patient |
| Q47169457 | Using the Native Afferent Nervous System to Sense Bladder Fullness: State of the Art. |
| Q126406844 | Voiding Dysfunction After Neobladder Urinary Diversion |
| Q41158255 | Voiding Dysfunction Associated with Pudendal Nerve Entrapment. |